Abstract
Prognosis (case series) Level of Evidence 4. To estimate the relative risk of developing a second primary neoplasm, in particular lung cancer, after having non-muscle-invasive bladder cancer (NMIBC). Patients were included in the study if they had developed NMIBC between 1995 and 2003. All clinical data were extracted from the medical records of our institution's database. The interval between neoplasms, smoking habits, histological subtypes and survival were also analysed. Patient follow-up was >or=5 years. We found 231 patients with NMIBC, 39 of which had a second primary neoplasm: 10 lung cancer, one pancreas, one gastric, one pharynx, one liver, one parathyroid, one oesophageal, five basal cell carcinoma, three larynx, two colon, three rectal and 10 prostate. In patients with lung cancer, NMIBC was the first primary tumour. Overall, the median (range) interval between occurrence of NMIBC and lung cancer was 54.2 (8-168) months. For the relationship between the observed and expected cases of lung cancer, after normalizing our frequencies to the sex ratio and age of our group of patients, the risk of lung cancer was 10.27-fold higher in patients with NMIBC as compared with the general population of Catalonia (95% confidence i...Continue Reading
References
Dec 1, 1978·Australasian Radiology·S L LangloisD W Henderson
Nov 1, 1991·Cancer Causes & Control : CCC·T SkovC Frølund
Nov 1, 1994·The Journal of Urology·E SalminenL Teppo
Feb 7, 1997·International Journal of Cancer. Journal International Du Cancer·A EngelandS Tretli
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J BlackD M Parkin
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Levi
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Levi
Sep 12, 2001·World Journal of Urology·J H MydloB M Grob
Dec 18, 2001·Urology·J H Mydlo, M Gerstein
Sep 25, 2002·Journal of Internal Medicine·H KuperH-O Adami
Jun 8, 2004·BJU International·A El-HakimG Weiss
Jul 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Claudine SamanicDebra T Silverman
Apr 9, 2008·Medical Oncology·Kunihiko MiyazakiKiyohisa Sekizawa
Apr 25, 2008·The Journal of Urology·Amar SinghGabriel P Haas
Apr 19, 2008·World Journal of Urology·M J MathersT Klotz
May 20, 2008·The Journal of Urology·Seth A Strope, James E Montie
May 27, 2008·Clinical Lung Cancer·Kyle E RusthovenBrian D Kavanagh
Citations
May 5, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Daniel VilenskyNeil E Fleshner
Jan 6, 2017·Oncology·Francesca SanguedolceLuigi Cormio
Mar 14, 2013·British Journal of Cancer·A P NoonJ W F Catto
Jul 31, 2020·European Radiology·Elisabeth O'DwyerMichelle S Ginsberg
Dec 24, 2020·AJR. American Journal of Roentgenology·Jose A B Araujo-FilhoMichelle S Ginsberg
Apr 24, 2021·Journal of the American College of Radiology : JACR·Suzanne C Byrne, Mark M Hammer